Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 18, 2017 - Issue 7-8
Submit an article Journal homepage
351
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Home care organization impacts patient management and survival in ALS

Sylvie LavernheDepartment of Neurology, University Hospital, Saint-Etienne, France,
,
Jean-Christophe AntoineDepartment of Neurology, University Hospital, Saint-Etienne, France, ;Reference Center for Motor Neuron Diseases and Amyotrophic Lateral Sclerosis, Saint-Etienne, France,
,
Isabelle Court-FortuneReference Center for Motor Neuron Diseases and Amyotrophic Lateral Sclerosis, Saint-Etienne, France, ;Department of Pulmonology, University Hospital, Saint-Etienne, France, and
,
Nathalie DimierDepartment of Neurology, University Hospital, Saint-Etienne, France, ;Reference Center for Motor Neuron Diseases and Amyotrophic Lateral Sclerosis, Saint-Etienne, France,
,
Frédéric CostesDepartment of Clinical Physiology, University Hospital, Saint-Etienne, France
,
Arnaud LacourDepartment of Neurology, University Hospital, Saint-Etienne, France,
&
Jean-Philippe CamdessanchéDepartment of Neurology, University Hospital, Saint-Etienne, France, ;Reference Center for Motor Neuron Diseases and Amyotrophic Lateral Sclerosis, Saint-Etienne, France, Correspondence[email protected]
 show all
Pages 562-568 | Received 13 Dec 2016, Accepted 15 May 2017, Published online: 06 Jun 2017

References

  • Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15:1245–51.
  • Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)-Revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
  • Miller RG, Mitchell JD, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev. 2012;14:CD001447.
  • Pouget J. Have ALS centers changed the care and management of amyotrophic lateral sclerosis? Rev Neurol (Paris). 2013;169:S39–S44.
  • Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry. 2003;74:1258–61.
  • Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Brooks BR, Sanjak M., Ringel S, England J, Brinkmann J, Pestronk A, et al. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group. Arch Neurol. 1996;53:141–7.
  • Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169:13–21.
  • Shoesmith CL, Findlater K, Rowe A, Strong MJ. Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry. 2007;78:629–31.
  • Soriani MH, Desnuelle C. Epidemiology of amyotrophic lateral sclerosis. Rev Neurol (Paris). 2009;165:627–40.
  • Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology. 2009;72:1087–94.
  • Manjaly ZR, Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, et al. The sex ratio in amyotrophic lateral sclerosis: A population based study. Amyotroph Lateral Scler. 2010;11:439–42.
  • Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, et al. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry. 2011;82:1165–70.
  • Pratt AJ, Getzoff ED, Perry JJ. Amyotrophic lateral sclerosis: update and new developments. Degener Neurol Neuromuscul Dis. 2012;2:1–14.
  • Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385–90.
  • Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10:310–23.
  • Turner MR, Barnwell J, Al-Chalabi A, Eisen A. Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain. 2012;135:2883–91.
  • Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff MM, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65:1264–7.
  • Chiò A, Bottacchi E, Buffa C, Mutani R, Mora G; PARALS. Positive effects of tertiary centers for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006;77:948–50.
  • Marin B, Beghi E, Vial C, Bernard E, Lautrette G, Clavelou P, et al. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. Eur J Neurol. 2016;23:787–95.
  • Abdelnour-Mallet M, Verschueren A, Guy N, Soriani MH, Chalbi M, Gordon P, et al. Safety of home parenteral nutrition in patients with amyotrophic lateral sclerosis: a French national survey. Amyotroph Lateral Scler. 2011;12:178–84.
  • Jennum P, Ibsen R, Pedersen SW, Kjellberg J. Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study. J Neurol. 2013;260:785–93.
  • Stephens HE, Young J, Felgoise SH, Simmons Z. A Qualitative Study of Multidisciplinary ALS Clinic Use in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17:55–61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.